Alvogen Buprenorphine and Naloxone Sublingual Film recalled for subpotent active ingredients
Alvogen, Inc. is recalling Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg due to out-of-specification assay results showing low levels of both naloxone and buprenorphine.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of a prescription drug affecting therapeutic efficacy. Subpotent active pharmaceutical ingredients in a critical medication (buprenorphine/naloxone used for pain management and opioid use disorder treatment) present significant risk of treatment failure and patient harm, meeting the Severe threshold for Class II recalls with potential for serious clinical consequences.
Plain-English summary
Alvogen, Inc. is recalling Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg nationwide. The affected product is distributed in 30-pouch cartons containing sublingual films (NDC 47781-355-03). Lot #36924 with expiration date 6/2021 has been identified as failing assay testing, with results showing out-of-specification levels of both naloxone and buprenorphine below the labeled amounts.
A total of 9,696 cartons have been distributed nationwide. Subpotent active ingredients may result in inadequate therapeutic efficacy, potentially compromising pain management and opioid use disorder treatment in affected patients.
Consumers and healthcare providers with this product should stop dispensing or using it and contact Alvogen, Inc. for further instructions. For more information, patients should consult their healthcare provider or pharmacist.
The recalled product
- Product
- BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)
- Brand
- BUPRENORPHINE AND NALOXONE
- Manufacturer
- Alvogen, Inc
- Affected units
- 9,696
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 36924
- Exp 6/2021
UPCs (8)
- 0347781356118
- 0347781358037
- 0347781355036
- 0347781357030
- 0347781356033
- 0347781358112
- 0347781357115
- 0347781355111
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · BUPRENORPHINE AND NALOXONE
- HighBuprenorphine and Naloxone Sublingual Tablets Recalled for Foreign Substance
FDA (Drugs) · 2022-11-09
Same manufacturer · Alvogen, Inc
See all →- ModerateCarotid anesthesia kits recalled over recalled B. Braun administration sets inside
FDA (Drugs) · 2026-01-21
- SevereFentanyl Transdermal Patches Recalled for Defective Delivery System
FDA (Drugs) · 2025-02-26
- ModeratePrescription Levothyroxine Sodium Tablets Recalled Due to Sub-Potency
FDA (Drugs) · 2023-03-08
- ModerateAlvogen Recalls Macrobid Nitrofurantoin Due to Failed Dissolution Specifications
FDA (Drugs) · 2019-08-21
- ModerateAlvogen Recalls Nitrofurantoin Capsules Due to Failed Dissolution Specifications
FDA (Drugs) · 2019-08-21
Same hazard · subpotent active ingredient
See all →- ModerateCVS Health Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22
- ModeratePremium Nature Instant Hand Sanitizer Recalled for Subpotent Ethanol
FDA (Drugs) · 2022-03-02
- ModeratePremium Nature Instant Hand Sanitizer Recalled for Subpotent Ethanol Content
FDA (Drugs) · 2022-03-02
- ModerateCariFree CTx36 Kit recalled for subpotent fluoride content
FDA (Drugs) · 2022-02-02
- ModeratePVP Iodine Prep Pads Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2021-09-01